The role of central nervous system endothelial cell activation in the pathogenesis of hepatic encephalopathy

Medical Hypotheses

Volumn 46, Issue 3, 1996, Pages 239-244

  Duchini, A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ACTIVITY; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; DISEASE COURSE; ENDOTHELIUM CELL; HEPATIC ENCEPHALOPATHY; HUMAN; HYPOTHESIS; PRIORITY JOURNAL; REVIEW;

EID: 0029887984     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(96)90248-0     Document Type: Article

References (58)

1. Knudsen G M, Hertz M M, Paulson OB. Metabolic disturbances of the blood-brain barrier with special emphasis on glucose and aminoacid transport. In: Neuwelt E A, ed. Implications of the Blood-brain Barrier and its Manipulations. New York: Plenum, 1989: 575-600.
2. McLain C J, Cohen D A. Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology 1989; 9: 349-351.
3. Lamas S, Michel T, Brenner B M, Mardsen P A. Nitric oxide synthesis in endothelial cells: evidence for a pathway inducible by TNF. Am J Physiol 1991; 261: C634-C641.
4. Vallance P, Moncada S. Hyperdynamic circulation in cirrhosis: a role for nitric oxide? Lancet 1991; 337: 776-778.
5. Tilg H, Wilmer A, Vogel W, Herold M, Nolchen B, Judmaier G, Huber C. Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992; 103: 264-274.
6. Sheron N, Bird G, Goka J, Alexander G, Williams R. Elevated plasma interleukin-6 and increased severity and mortality in alcoholic hepatitis. Clin Exp Immunol 1991; 84: 449-453.
7. Felver M E, Mezey E, McGuire M et al. Plasma tumor necrosis factor α predicts decreased long-term survival in severe alcoholic hepatitis. Alcoh Clin Exp Res 1990; 14(2): 255-259.
8. Hoyumpa A M, Desmond P V, Avant G R, Roberts R K, Schenker S. Hepatic encephalopathy. Gastroenterology 1979; 76(1): 184-195.
9. Ayala A, Perrin M M, Meldrum D R, Ertel W, Chaudry L H. Hemorrhage induces an increase in serum TNF which is not associated with increased levels of endotoxin. Cytokine 1990; 2: 170-174.
10. Ertel W, Morrison M H, Ayala A, Perrin M M, Chaudry I H. Anti-TNF monoclonal antibodies prevent haemorrhage-induced suppression of Kupffer cell antigen presentation and MHC class II antigen expression. Immunology 1991; 74: 290-297.
11. Propst T, Propst A, Herold M, Judmaier G, Braunsteiner H, Vogel W. High levels of Interleukin 6 and its secondary mediators in spontaneous bacterial peritonitis. Gastroenterology 1993; 105(1): 310-311.
12. Marks J D, Marks C B, Luce J M et al. Plasma TNF in patients with septic shock. Mortality rate, incidence of adult respiratory distress syndrome and effects of methylprednisolone administration. Am Rev Respir Dis 1990; 141(1): 94-97.
13. Hack C E, DeGroot E R, Felt-Bersma R J et al. Increased plasma levels of interleukin-6 in sepsis. Blood 1989; 74: 1704-1710.
14. Byl B, Roucloux I, Crusioux A, Dupont E, Deviere J. TNF and IL-6 plasma levels in infected cirrhotic patients. Gastroenterology 1993; 104: 1492-1497.
15. Beutler B A, Milsark I A, Cerami A. Cachectin/tumor necrosis factor: production, distribution and metabolic fate in vivo. J Immunol 1985; 135: 3972-3977.
16. Ferraiolo B L, Moore J A, Crase D, Gribling P, Wilking H, Baughman R A. Pharmacokinetics and tissue distribution of recombinant human tumor necrosis factor in mice. Drug Metab Dispos 1988; 16: 270-275.
17. Benelmans M H, Gouma D J, Buurman W A. Influence of nephrectomy on tumor necrosis factor clearance in a murine model. J Immunol 1993; 150(5): 2007-2017.
18. Taupin V, Toulmond S, Serrano A, Benavides J, Zavala F. Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion. J Neuroimmunol 1993; 42: 177-186.
19. Andus T, Bauer J, Gerok W. Effects of cytokines on the liver. Hepatology 1991; 13: 364-375.
20. Connell C J, Mercer K L. Freeze-fracture appearance of the capillary endothelium in the cerebral cortex of mouse brain. Am J Anat 1974; 140: 595-600.
21. Huhynh H K, Dorovini-Zis K. Effects of interferon-γ on primary cultures of human brain microvessel endothelial cells. Am J Pathol 1993, 142(4): 1265-1278.
22. Camussi G, Turello E, Bussolino F, Baglioni C. Tumor necrosis factor alters cytoskeletal organization and barrier function of endothelial cells. Int Arch Allergy Appl Immunol 1991; 96: 84-91.
23. Maruo N, Morita I, Shirao M, Murota S I. IL-6 increases endothelial permeability in vitro. Endocrinology 1992; 131: 710-714.
24. Quagliarello V J, Wispelwey B, Long W J, Scheld W M. Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. J Clin Invest 1991; 87: 1360-1366.
25. Sharieff M K, Thompson E J. In vivo relationship of tumor necrosis factor to blood-brain barrier damage in patients with active multiple sclerosis. J Neuroimmunol 1992; 38: 27-34.
26. Cotran R S, Pober J S, Gimbrone M A et al. Endothelial activation during interleukin-2 (IL-2) immunotherapy: a possible mechanism for the vascular leak syndrome. J Immunol 1988; 140: 1883-1889.
27. Pober J S. Cytokine-mediated activation of vascular endothelium. Am J Pathol 1988; 133(3): 426-433.
28. Hofman F M. Cytokines in central nervous system disease. Neuroimmune Networks: Physiology and Diseases. New York: Alan R. Liss, 1989: 65-71.
29. Blei AT. Hepatic encephalopathy. In: Kaplowitz N, ed. Liver and Biliary Diseases. Baltimore, MD: Williams and Wilkins, 1992: 552-565.
30. McClung H J, Sloan H R, Powers P et al. Early changes in the permeability of the blood-brain barrier produced by toxins associated with liver failure. Ped Res 1990; 28(3): 227-231.
31. Potvin M, Finlayson M H, Hinchey E J, Lough J O, Goresky C A. Cerebral abnormalities in hepatectomized rats with acute hepatic coma. Lab Invest 1984; 50(5): 560-564.
32. Zaki A E O, Ede R J, Davis M, Williams R. Experimental studies of blood-brain barrier permeability in acute hepatic failure. Hepatology 1984; 4(3): 359-363.
33. Horowitz M E, Schafer D F, Molnar P et al. Increased blood-brain transfer in a rabbit model of acute liver failure. Gastroenterology 1983; 84: 1003-1011.
34. Lockwood A H, Yap EWH, Wong W H. Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy. J Cereb Blood Flow Metab 1991; 11: 337-341.
35. Knudsen G M, Schmidt J, Almdal T, Paulson O B, Vilstrup H. Passage of amino acids and glucose across the blood-brain barrier in patients with hepatic encephalopathy. Gastroenterology 1993; 17: 987-992.
36. Wahler J B, Swain M G, Carson R, Bergasa N V, Jones E A. Blood-brain barrier permeability is markedly decreased in cholestasis in the rat. Hepatology 1993; 17: 1103-1108.
37. Tominaga S, Watanabe A, Tsuji T. Synergistic effect of bile acid, endotoxin and ammonia on brain edema. Metab Brain Dis 1991; 6(2): 93-105.
38. Zieve L, Lyftogt C. Effect of endotoxin and immunoglobulin on the course of experimental hepatic encephalopathy. Metab Brain Dis 1988; 3(3): 229-233.
39. Liehr H, Grün M. Endotoxins in liver disease. In: Popper H, Schafner F, eds. Progress in Liver Disease. New York: Grune and Stratton, 1979: 313-326.
40. Chensue S W, Terebuh P D, Remick D G, Scales W E, Kunkel S L. In vivo biologic and immunohistochemical analysis of interleukin-1 alpha, beta and tumor necrosis factor during experimental endotoxemia. Am J Pathol 1991; 138(2): 395-402.
41. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43(2): 109-142.
42. Claria J, Jimenez W, Ros J et al. Pathogenesis of arterial hypotension in cirrhotic rats with ascites: role of endogenous nitric oxide. Hepatology 1992; 15: 343-349.
43. Hunt N C A, Goldin R D. Nitric oxide production by monocytes in alcoholic liver disease. J Hepatol 1992; 14: 146-150.
44. Kilbourn R G, Belloni P. Endothelial cell production of nitrogen oxides in response to Interferon gamma in combination with tumor necrosis factor, interleukin-1 or endotoxin. J Natl Cancer Inst 1990; 82: 772-776.
45. Marsault R, Frelin C. Activation by nitric oxide of guanylate cyclase in endothelial cells from brain capillaries. J Neurochem 1992; 59: 942-945.
46. Hibbs J B, Taintor R R, Vavrin Z. Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science 1987; 235: 473-476.
47. Nuremberg M D. The role of astrocytes in hepatic encephalopathy. Neurochem Pathol 1987; 6: 13-33.
48. Adams R D, Foley J M. The neurological disorder associated with liver disease. Assoc Res Nerv Ment Dis Proc 1953; 32: 198-237.
49. Livingstone A S, Potvin M, Goresky C A, Finlayson M H, Hinchey E J. Changes in the blood-brain barrier in hepatic coma after hepatectomy in the rat. Gastroenterology 1977; 73: 697-704.
50. Selmaj K W, Shafit-Zayardi B, Aquino D A et al. TNF-induced proliferation of astrocytes from mature brain is associated with down-regulation of glial fibrillary acidic protein mRNA. J Neurochem 1991; 57(3): 823-830.
51. Kimura T, Budka H. Glial fibrillary acidic protein and S-100 protein in human hepatic encephalopathy: immunocytochemical demonstration of dissociation of two glia-associated proteins. Acta Neuropathol 1986; 70: 17-21.
52. Sobel R A, DeArmond S J, Fomo L S, Eng L F. Glial fibrillary acidic protein in hepatic encephalopathy. An immunohistochemical study. J Neuropathol Exp Neurol 1981; 40: 625-632.
53. Bodega G, Suarez I, Arilla E, Rubio M, Fernandez B. Heterogeneous astroglial response in the rat spinal cord to long-term portacaval shunt: an immunohistochemical study. Glia 1991; 4: 400-407.
54. Merrill J E. Effects of interleukin-l and tumor necrosis factor α on astrocytes, microglia, oligodendrocytes, and glial precursors in vitro. Dev Neurosci 1991; 13: 130-137.
55. Sawada M, Suzumura A, Marunouchi T. TNFα induces IL-6 production by astrocytes but not by microglia. Brain Res 1992; 583: 296-299.
56. Giulian D, Lachman L B. Interleukin-1 stimulates astroglial proliferation after brain injury. Science 1985; 228: 497-499.
57. Cole M, Rutherford R B, Smith F O. Experimental ammonia encephalopathy in the primate. Arch Neurol 1972; 26: 130-136.
58. Selmaj K W, Raine C S. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 1988; 23: 399-346.